After more than 15 years, the battle between the Canada Revenue Agency and Glaxo Canada over the transfer price for ranitidine—the active pharmaceutical ingredient used to make the branded, anti-ulcer drug Zantac—finally reached the Supreme Court of Canada (SCC) last month.
Law360's 2024 Editorial Boards
Congratulations to Forensic Services’ Kristopher Hult, John Rademacher, and Transfer Pricing’s Anna Soubbotina on being accepted into Law360’s advisory board....